EUVIMEDEUVIMED entdecken
Crossref

Low-Salicylate Diet in Patients with Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: Personalization of Indications to Dietary Treatment

Edyta Jura-Szoltys, Barbara Rymarczyk, Radoslaw Gawlik, Joanna Glück

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000539917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Edyta Jura-Szoltys und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Sinusitis, Salicylates, Asthma, Aspirin-Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A particularly aggressive course of chronic sinusitis with nasal polyps is seen in patients with bronchial asthma and hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs). These patients often report exacerbation associated with consumption of foods reach in salicylates. Therefore, the authors analyzed the effect of a low-salicylate diet (LSD) on the course of chronic sinusitis with polyps in patients with NSAID-exacerbated respiratory disease (N-ERD) to answer the question: which patients would obtain the best therapeutic benefit?

Methods

Adult patients with N-ERD were selected for dietary intervention with LSD. Patients were seen on two occasions: at an initial visit and a follow-up after 12 weeks of diet. At both visits, an evaluation was performed with total nasal symptom score (TNSS) and modified Lund-Kennedy (L-K) endoscopy score.

Results

Forty patients (21 female, 52.5%, median and IQR of age 52; 43.5–61) used LSD for 12 weeks. Initial analysis of dietary intervention in the whole group revealed a significant decrease in TNSS and each symptom assessed separately, and the L-K score. The group was further divided into two subgroups based on the distance between NSAID intake and the beginning of symptoms: patients with immediate (n = 9; 22.5%) or non-immediate (n = 31; 77.5%) symptoms. The absolute change in nasal obstruction, itching, TNSS, and L-K scores were significantly higher in patients with immediate than with non-immediate symptoms.

Conclusion

Results of the study indicate that patients with N-ERD and immediate symptoms may clinically benefit more from an LSD as an additional therapeutic option than patients with non-immediate symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalSinusitisSalicylatesAsthma, Aspirin-InducedHumansFemaleMaleMiddle AgedAdultTreatment OutcomeNasal PolypsChronic Disease

Stichwörter der Autor:innen

Chronic rhinosinusitisHypersensitivity reactionLow-salicylate dietNasal polypsNon-steroidal anti-inflammatory drug-exacerbated respiratory disease

Substanzen

Anti-Inflammatory Agents, Non-SteroidalSalicylates

Autor:innen und Institutionen

  • Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.

Zitieren

APA

Jura-Szoltys, E., Rymarczyk, B., Gawlik, R., & Glück, J. (2024). Low-Salicylate Diet in Patients with Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: Personalization of Indications to Dietary Treatment. International Archives of Allergy and Immunology. https://doi.org/10.1159/000539917

Vancouver

Jura-Szoltys E, Rymarczyk B, Gawlik R, Glück J. Low-Salicylate Diet in Patients with Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: Personalization of Indications to Dietary Treatment. International Archives of Allergy and Immunology. 2024. doi:10.1159/000539917

BibTeX
@article{JuraSzoltys2024,
  author = {Jura-Szoltys, Edyta and Rymarczyk, Barbara and Gawlik, Radoslaw and Glück, Joanna},
  title = {Low-Salicylate Diet in Patients with Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: Personalization of Indications to Dietary Treatment},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000539917}
}
Kostenlos starten →